Fennec Pharmaceuticals Inc.(FENC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

FENC Fennec Pharmaceuticals Inc.

Market Closed 05-03 16:00:00 EDT

9.23

+0.14

+1.54%

盘后9.23

+0.000.00%

16:04 EDT

High9.38	Low9.15	Vol71.28K
Open9.23	D1 Closing9.09	Amplitude2.53%
Mkt Cap252.14M	Tradable Cap142.24M	Total Shares27.32M
T/O660.06K	T/O Rate0.46%	Tradable Shares15.41M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"FENC","market":"US","secType":"STK","nameCN":"Fennec Pharmaceuticals Inc.","latestPrice":9.23,"timestamp":1714766400000,"preClose":9.09,"halted":0,"volume":71279,"hourTrading":{"tag":"盘后","latestPrice":9.23,"preClose":9.23,"latestTime":"16:04 EDT","volume":2782,"amount":25677.86,"timestamp":1714766657318},"delay":0,"floatShares":15410565,"shares":27317241,"eps":-0.603785,"marketStatus":"Market Closed","change":0.14,"latestTime":"05-03 16:00:00 EDT","open":9.23,"high":9.38,"low":9.15,"amount":660057.8823,"amplitude":0.025303,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.603785,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1714982400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":9.09,"postHourTrading":{"tag":"盘后","latestPrice":9.23,"preClose":9.23,"latestTime":"16:04 EDT","volume":2782,"amount":25677.86,"timestamp":1714766657318},"volumeRatio":0.7724108470735757},"requestUrl":"/m/hq/s/FENC","defaultTab":"news","newsList":[{"id":"2432998947","title":"Will Adherex Technologies Inc. (FENC) Report Negative Q1 Earnings? What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2432998947","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2432998947?lang=en_us&edition=fundamental","pubTime":"2024-05-02 22:01","pubTimestamp":1714658466,"startTime":"0","endTime":"0","summary":"Wall Street expects a year-over-year increase in earnings on higher revenues when Adherex Technologies Inc.  reports results for the quarter ended March 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.This company is expected to post quarterly loss of $0.04 per share in its upcoming report, which represents a year-over-year change of +82.6%.Revenues are expected to be $10.41 million, up 519.6% from the ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/QOfludHza1dTKV8R6Coeiw--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/QOfludHza1dTKV8R6Coeiw--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adherex-technologies-inc-fenc-report-140106578.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426149648","title":"Those who invested in Fennec Pharmaceuticals (NASDAQ:FENC) five years ago are up 136%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426149648","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2426149648?lang=en_us&edition=fundamental","pubTime":"2024-04-10 01:53","pubTimestamp":1712685223,"startTime":"0","endTime":"0","summary":"When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really flourishing, you can make more than 100%. Long term Fennec Pharmaceuticals Inc.  shareholders would be well aware of this, since the stock is up 136% in five years. And in the last month, the share price has gained 12%. This could be related to the recent financial results that were recently released - you could check the most recent data by reading our company report.With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.Get in touch with us directly. Alternatively, email","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/those-invested-fennec-pharmaceuticals-nasdaq-175343672.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2424361064","title":"Fennec Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2424361064","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2424361064?lang=en_us&edition=fundamental","pubTime":"2024-04-04 18:32","pubTimestamp":1712226720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FENC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 04, 2024 06:32 ET (10:32 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2420472272","title":"Fennec (FENC) Signs Licensing Deal With Norgine, Stock Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2420472272","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2420472272?lang=en_us&edition=fundamental","pubTime":"2024-03-19 22:14","pubTimestamp":1710857640,"startTime":"0","endTime":"0","summary":"Fennec Pharmaceuticals Inc. FENC announced that it has entered into an exclusive licensing deal with Norgine, a European specialist pharmaceutical company, to develop and commercialize its only marketed product, Pedmark/Pedmarqsi , inEU,Australia and New Zealand.Fennec initially received FDA approval for Pedmark in 2022, granting marketing permission in the U.S. market as the first and only treatment to reduce the risk of ototoxicity  associated with cisplatin in pediatric patients aged one month and older with localized and non-metastatic solid tumors.Fennec’s stock gained 11.4% on Mar 18 as the investors were impressed by the company’s efforts to expand Pedmarqsi’s accessibility to patients across the globe who are at risk of suffering from cisplatin-induced ototoxicity. The influx of cash from the upfront payment, yet to be received, is also expected to strengthen FENC’s balance sheet, which might have also contributed to the rise in share prices.In the past year, shares of Fennec h","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/X_G78K7TS0Wks9k_NbYhwg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/X_G78K7TS0Wks9k_NbYhwg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fennec-fenc-signs-licensing-deal-141400094.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2420461754","title":"BRIEF-Fennec Pharmaceuticals And Norgine Enter Into Exclusive Licensing Agreement To Commercialize Pedmarqsi In Europe, Australia, And New Zealand","url":"https://stock-news.laohu8.com/highlight/detail?id=2420461754","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2420461754?lang=en_us&edition=fundamental","pubTime":"2024-03-18 09:01","pubTimestamp":1710723707,"startTime":"0","endTime":"0","summary":"March 17  - Fennec Pharmaceuticals Inc :   * FENNEC PHARMACEUTICALS AND NORGINE ENTER INTO EXCLUSIVE LICENSING AGREEMENT TO COMMERCIALIZE PEDMARQSI IN EUROPE, AUSTRALIA, AND NEW ZEALAND   * WILL RECEIVE EUR 40 MILLION IN UPFRONT AND UP TO EUR 210 MILLION IN ADDITIONAL COMMERCIAL AND REGULATORY MILESTONES,   * FENNEC - NORGINE WILL BE RESPONSIBLE FOR  COMMERCIALIZATION ACTIVITIES IN LICENSED TERRITORIES AND WILL HOLD ALL MARKETING AUTHORIZATIONS THERESource text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2420461082","title":"Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand","url":"https://stock-news.laohu8.com/highlight/detail?id=2420461082","media":"StreetInsider","top":-1,"share":"https://ttm.financial/m/news/2420461082?lang=en_us&edition=fundamental","pubTime":"2024-03-18 09:00","pubTimestamp":1710723600,"startTime":"0","endTime":"0","summary":"Agreement pairs Norgine’s commercial expertise and leading European footprint with PEDMARQSI, the first and only approved therapy in the European Union and U.K. for reducing the risk of cisplatin-indu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.streetinsider.com/dr/news.php?id=22941122","is_publish_highlight":false,"gpt_icon":0},{"id":"2408636271","title":"Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and Societal CDMO (SCTL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2408636271","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2408636271?lang=en_us&edition=fundamental","pubTime":"2024-02-01 22:10","pubTimestamp":1706796619,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Fennec Pharmaceuticals (FENC – Research Report) and ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fennec-pharmaceuticals-fenc-and-societal-cdmo-sctl?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fennec-pharmaceuticals-fenc-and-societal-cdmo-sctl?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fennecpharma.com","stockEarnings":[{"period":"1week","weight":0.0022},{"period":"1month","weight":-0.143},{"period":"3month","weight":-0.0834},{"period":"6month","weight":0.3377},{"period":"1year","weight":0.1466},{"period":"ytd","weight":-0.1774}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. The company's product candidates include PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity hearing loss in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":-0.012234},{"month":2,"riseRate":0.571429,"avgChangeRate":0.018842},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.020679},{"month":4,"riseRate":0.571429,"avgChangeRate":-0.021313},{"month":5,"riseRate":0.428571,"avgChangeRate":0.006973},{"month":6,"riseRate":0.5,"avgChangeRate":0.038502},{"month":7,"riseRate":0.666667,"avgChangeRate":0.026967},{"month":8,"riseRate":0.5,"avgChangeRate":-0.036198},{"month":9,"riseRate":0.666667,"avgChangeRate":0.058778},{"month":10,"riseRate":0.428571,"avgChangeRate":0.012399},{"month":11,"riseRate":0.714286,"avgChangeRate":-0.002651},{"month":12,"riseRate":0.571429,"avgChangeRate":0.038013}],"exchange":"NASDAQ","name":"Fennec Pharmaceuticals Inc.","nameEN":"Fennec Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fennec Pharmaceuticals Inc.(FENC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Fennec Pharmaceuticals Inc.(FENC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Fennec Pharmaceuticals Inc.,FENC,Fennec Pharmaceuticals Inc.股票,Fennec Pharmaceuticals Inc.股票老虎,Fennec Pharmaceuticals Inc.股票老虎国际,Fennec Pharmaceuticals Inc.行情,Fennec Pharmaceuticals Inc.股票行情,Fennec Pharmaceuticals Inc.股价,Fennec Pharmaceuticals Inc.股市,Fennec Pharmaceuticals Inc.股票价格,Fennec Pharmaceuticals Inc.股票交易,Fennec Pharmaceuticals Inc.股票购买,Fennec Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fennec Pharmaceuticals Inc.(FENC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Fennec Pharmaceuticals Inc.(FENC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction